A0A2Z5XAK1 (A0A2Z5XAK1_PSESP) Pseudomonas sp
Metallo-beta-lactamase type 2 UniProtKBAFDB90v4InterProInteractive Modelling
266 aa; Sequence (Fasta) ;
37 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
87 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
VIM-2-2, Discovery of novel inhibitor scaffolds against the metallo- beta-lactamase VIM-2 by SPR ba… | homo-2-mer | 6×ZN; 2×WL3; 2×OH; 4×CL; | ||||
Assess | ||||||
VIM-2-OX, Discovery of novel inhibitor scaffolds against the metallo- beta-lactamase VIM-2 by SPR b… | homo-2-mer | 2×OH; 4×ZN; 4×CL; | ||||
Assess | ||||||
Directed evolutionary changes in MBL super family - VIM-2 Round 10 | homo-2-mer | 2×ZN; 1×GOL; | ||||
Assess | ||||||
The structure of the metallo-beta-lactamase VIM-2 in complex with a triazolylthioacetamide 1b | homo-2-mer | 4×ZN; 4×CL; 2×MG; 4×NA; 2×9RX; 2×ACT; 2×FMT; | ||||
Assess | ||||||
VIM-2 metallo-beta-lactamase in complex with ((S)-3-mercapto-2-methylpropanoyl)-L-tryptophan (Compo… | monomer | 3×ZN; 1×R59; 2×FMT; 1×BEZ; | ||||
Assess | ||||||
Structure of metallo beta lactamase VIM-2 with cyclic boronate APC308. | monomer | 1×KDZ; 1×KL8; 3×ZN; 2×CL; | ||||
Assess | ||||||
Crystal Structure of the VIM-2 Acquired Metallo-beta-Lactamase in Complex with the thiazolecarboxyl… | monomer | 3×ZN; 2×ACT; 1×QKK; | ||||
Assess | ||||||
Crystal structure of the VIM-2 acquired metallo-beta-Lactamase in complex with compound 28 (JMV-703… | monomer | 3×ZN; 2×ACT; 1×7ZN; | ||||
Assess | ||||||
VIM-2-1, Discovery of novel inhibitor scaffolds against the metallo- beta-lactamase VIM-2 by SPR ba… | monomer | 3×ZN; 2×RHU; 2×CL; 1×OH; | ||||
Assess | ||||||
Crystal Structure of VIM-2 with Compound 16 | monomer | 4×ZN; 1×L8J; 3×ACT; | ||||
Assess | ||||||
Crystal structure of the metallo-beta-lactamase VIM-2 with L-captopril | monomer | 1×NA; 1×X8Z; 2×FMT; 3×ZN; | ||||
Assess | ||||||
Structure of VIM-2 metallo-beta-lactamase with hydrolysed Faropenem imine product | monomer | 1×QZH; 3×ZN; 2×CL; 1×MG; 1×NA; | ||||
Assess | ||||||
Crystal structure of the metallo-beta-lactamase VIM-2 | monomer | 1×NA; 3×FMT; 3×ZN; | ||||
Assess | ||||||
Crystal structure of the metallo-beta-lactamase VIM-2 with D-captopril | monomer | 1×NA; 1×MCO; 3×FMT; 3×ZN; | ||||
Assess | ||||||
Metallo beta-lactamase VIM2 with compound AK4 | monomer | 1×ZJ5; 3×ZN; 3×CL; 1×NA; | ||||
Assess | ||||||
Crystal structure of the metallo-beta-lactamase VIM-2 with 2C | monomer | 2×FMT; 3×ZN; 1×OK3; 1×DMS; | ||||
Assess | ||||||
Structure of VIM-2 with 2-Mercaptomethyl-thiazolidine D-syn-1b | monomer | 3×ZN; 2×FMT; 1×QST; | ||||
Assess | ||||||
Crystal Structure Of VIM-2 Metallo-beta-lactamase In Complex With Inhibitor X2 | monomer | 3×ZN; 2×FMT; 1×E1C; | ||||
Assess | ||||||
Crystal structure of VIM-2 in complex with triazole-based inhibitor OP24 | monomer | 3×ZN; 4×FMT; 1×N8Z; | ||||
Assess | ||||||
Crystal structure of the metallo-beta-lactamase VIM2 with 139 | monomer | 3×ZN; 1×R9K; 3×FMT; | ||||
Assess | ||||||
Crystal Structure of the Acquired VIM-2 Metallo-beta-Lactamase in Complex with ANT-330 Inhibitor | monomer | 3×ZN; 1×ACT; 2×JTY; | ||||
Assess | ||||||
Crystal structure of the VIM-2 acquired metallo-beta-Lactamase in Complex with compound 14 (JMV-693… | monomer | 3×ZN; 2×ACT; 1×UNL; | ||||
Assess | ||||||
Crystal structure of the VIM-2 acquired metallo-beta-Lactamase in Complex with compound 8 (JMV-7207) | monomer | 3×ZN; 2×ACT; 1×1TH; | ||||
Assess | ||||||
Crystal structure of the VIM-2 acquired metallo-beta-Lactamase in Complex with compound 10 (JMV-721… | monomer | 3×ZN; 2×ACT; 1×UNL; | ||||
Assess | ||||||
VIM-2 metallo-beta-lactamase in complex with 2-(3-fluoro-4-hydroxyphenyl)-3-oxoisoindoline-4-carbox… | monomer | 3×ZN; 2×FMT; | ||||
Assess | ||||||
VIM-2 metallo-beta-lactamase in complex with 2-(2-chloro-6-fluorobenzyl)-3-oxoisoindoline-4-carboxy… | monomer | 2×ZN; 1×6UW; 1×FMT; 2×GOL; | ||||
Assess | ||||||
Structure of VIM-2 with 2-Mercaptomethyl-thiazolidine L-anti-1b | monomer | 3×ZN; 1×QT2; 2×FMT; | ||||
Assess | ||||||
Crystal structure of VIM-2 MBL in complex with (2-(4-phenyl-1H-1,2,3-triazol-1-yl)benzyl)phosphonic… | monomer | 2×ZN; 1×ITV; | ||||
Assess | ||||||
Crystal structure of VIM-2 with hydrolyzed faropenem (ring-open form) | monomer | 2×FMT; 3×ZN; 1×QZH; | ||||
Assess | ||||||
Crystal Structure of VIM-2 metallo-beta-lactamase in complex with ML302 and ML302F | monomer | 3×ZN; 1×S3C; 1×SVB; 2×FMT; 1×DMS; | ||||
Assess | ||||||
Crystal Structure Of VIM-2 Metallo-beta-lactamase In Complex With Inhibitor NO9 | monomer | 3×ZN; 2×MG; 2×NO9; 2×FMT; | ||||
Assess | ||||||
VIM-2_1dj- Triazole inhibitors with promising inhibitor effects against antibiotic resistance metal… | monomer | 3×ZN; 1×OH; 2×CL; 1×9O8; 1×IOD; | ||||
Assess | ||||||
VIM-2 metallo-beta-lactamase in complex with benzebisheterocycle compound 14 | monomer | 3×FMT; 3×ZN; 1×Y4E; | ||||
Assess | ||||||
Metallo-Beta-Lactamase VIM-2 in complex with Dual MBL/SBL Inhibitor MS01 | monomer | 2×ZN; 1×BHU; 7×FMT; 3×GOL; | ||||
Assess | ||||||
Crystal structure of VIM-2 metallo-beta-lactamase in complex with 10-HHIA | monomer | 3×ZN; 2×FMT; | ||||
Assess | ||||||
Crystal structure of VIM-2 MBL in complex with 1-isopropyl-1H-imidazole-2-carboxylic acid | monomer | 3×ZN; 1×HKU; 2×FMT; | ||||
Assess | ||||||
Crystal structure of VIM-2 MBL in complex with 1-cyclobutyl-1H-imidazole-2-carboxylic acid | monomer | 3×ZN; 1×HM0; 2×FMT; | ||||
Assess | ||||||
Crystal structure of VIM-2 MBL in complex with 1-(4-(trifluoromethyl)benzyl)-1H-imidazole-2-carboxy… | monomer | 2×ZN; 1×HML; 2×GOL; | ||||
Assess | ||||||
Metallo-Beta-Lactamase VIM-2 in complex with Dual MBL/SBL Inhibitor MS19 | monomer | 3×ZN; 1×BY0; 3×FMT; | ||||
Assess | ||||||
Crystal structure of VIM-2 MBL in complex with 3-(4-(4-(2-aminoethoxy)phenyl)-1H-1,2,3-triazol-1-yl… | monomer | 2×ZN; 1×IU7; | ||||
Assess | ||||||
Crystal structure of VIM-2 complexed with compound 14 | monomer | 3×ZN; 2×M3Q; 2×ACT; | ||||
Assess | ||||||
Crystal Structure OF VIM-2 Metallo-beta-lactamase | monomer | 3×ZN; 2×FMT; | ||||
Assess | ||||||
Crystal structure of B1 VIM-2 MBL in complex with 2-amino-5-(2-(thiophen-2-yl)ethyl)thiazole-4-carb… | monomer | 2×ZN; 1×60J; | ||||
Assess | ||||||
VIM-2 Metallo Beta Lactamase in complex with 3-(mercaptomethyl)-[1,1'-biphenyl]-4-carboxylic acid | monomer | 1×S5Z; 3×FMT; 3×ZN; | ||||
Assess | ||||||
Metallo-Beta-Lactamase VIM-2 in complex with (S)-N-(3-(2H-tetrazol-5-yl)phenyl)-3-mercapto-2-methyl… | monomer | 2×ZN; 1×FMT; 1×G0O; | ||||
Assess | ||||||
Crystal structure of VIM-2 MBL in complex with 1-propyl-1H-imidazole-2-carboxylic acid | monomer | 3×ZN; 1×HKR; 2×FMT; | ||||
Assess | ||||||
Crystal structure of VIM-2 MBL in complex with 1-((2-aminobenzo[d]thiazol-6-yl)methyl)-1H-imidazole… | monomer | 2×ZN; 1×HQF; 1×PEG; | ||||
Assess | ||||||
Crystal structure of VIM-2 MBL in complex with (R)-1-(sec-butyl)-1H-imidazole-2-carboxylic acid | monomer | 3×ZN; 1×HL3; 2×FMT; | ||||
Assess | ||||||
Crystal Structure of the Acquired VIM-2 Metallo-beta-Lactamase in Complex with ANT-431 Inhibitor | monomer | 3×ZN; 2×ACT; 1×G1N; | ||||
Assess | ||||||
VIM-2 metallo-beta-lactamase in complex with (R)-2-(4-hydroxyphenyl)-2-((S)-3-mercapto-2-methylprop… | monomer | 3×ZN; 1×8PO; 2×FMT; | ||||
Assess | ||||||
Crystal structure of VIM-2 MBL in complex with 1-(but-3-en-1-yl)-4-methyl-1H-imidazole-2-carboxylic… | monomer | 2×ZN; 1×HQR; 1×GOL; | ||||
Assess | ||||||
Crystal structure of B1 VIM-2 MBL in complex with 2-amino-5-isobutylthiazole-4-carboxylic acid | monomer | 2×ZN; 1×5IY; | ||||
Assess | ||||||
Crystal structure of B1 VIM-2 MBL in complex with 2-amino-5-(thiophen-2-ylmethyl)thiazole-4-carboxy… | monomer | 2×ZN; 1×5ZU; | ||||
Assess | ||||||
Crystal structure of B1 VIM-2 MBL in complex with 2-amino-5-(but-3-en-1-yl)thiazole-4-carboxylic ac… | monomer | 2×ZN; 1×5YT; | ||||
Assess | ||||||
Crystal structure of B1 VIM-2 MBL in complex with 2-amino-5-pentylthiazole-4-carboxylic acid | monomer | 2×ZN; 1×5Z2; 1×FMT; | ||||
Assess | ||||||
Crystal structure of VIM-2 MBL in complex with 1-(4-hydroxybenzyl)-1H-imidazole-2-carboxylic acid | monomer | 3×ZN; 1×HN9; 2×FMT; | ||||
Assess | ||||||
Crystal structure of VIM-2 MBL in complex with 1-(but-3-en-1-yl)-1H-imidazole-2-carboxylic acid | monomer | 2×ZN; 1×HLF; 1×GOL; | ||||
Assess | ||||||
Crystal structure of VIM-2 MBL in complex with 1-(2-(1H-1,2,3-triazol-1-yl)ethyl)-1H-imidazole-2-ca… | monomer | 2×ZN; 1×HLL; | ||||
Assess | ||||||
Crystal structure of B1 VIM-2 MBL in complex with 2-amino-5-phenethylthiazole-4-carboxylic acid | monomer | 2×ZN; 1×5ZX; 3×FMT; | ||||
Assess | ||||||
Crystal Structure of VIM-2 metallo-beta-lactamase in complex with ML302F | monomer | 3×ZN; 1×S3C; 2×FMT; | ||||
Assess | ||||||
Crystal Structure of the Acquired VIM-2 Metallo-beta-Lactamase in Complex with ANT-90 Inhibitor | monomer | 3×ZN; 1×U8K; 1×CL; 2×ACT; | ||||
Assess | ||||||
VIM-2-NAT, Discovery of novel inhibitor scaffolds against the metallo- beta-lactamase VIM-2 by SPR … | monomer | 1×OH; 3×ZN; 2×CL; | ||||
Assess | ||||||
Crystal structure of VIM-2 MBL in complex with 3-(4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl)phthalic … | monomer | 2×ZN; 1×IU3; | ||||
Assess | ||||||
Metallo-Beta-Lactamase VIM-2 in complex with 1-benzyl-1H-imidazole-2-carboxylic acid | monomer | 3×ZN; 1×FZX; 2×FMT; | ||||
Assess | ||||||
Crystal structure of B1 VIM-2 MBL in complex with 2-amino-5-heptylthiazole-4-carboxylic acid | monomer | 2×ZN; 1×5ZR; 2×FMT; | ||||
Assess | ||||||
Crystal structure of B1 VIM-2 MBL in complex with 2-amino-5-(4-methoxybenzyl)thiazole-4-carboxylic … | monomer | 2×ZN; 1×4YJ; | ||||
Assess | ||||||
Crystal structure of B1 VIM-2 MBL in complex with 2-amino-5-hexylthiazole-4-carboxylic acid | monomer | 2×ZN; 1×5ZD; | ||||
Assess | ||||||
Crystal structure of VIM-2 MBL in complex with 1-benzyl-5-methyl-1H-imidazole-2-carboxylic acid | monomer | 2×ZN; 1×HQ3; | ||||
Assess | ||||||
Crystal structure of VIM-2 MBL in complex with 1-(but-3-en-1-yl)-5-methyl-1H-imidazole-2-carboxylic… | monomer | 2×ZN; 1×HQ0; | ||||
Assess | ||||||
VIM-2_1cc-. Triazole inhibitors with promising inhibitor effects against antibiotic resistance meta… | monomer | 1×9NW; 2×ZN; 1×OH; | ||||
Assess | ||||||
Structure of VIM-2 bound to QPX7728 at 1.20 A | monomer | 1×QNA; 3×ZN; 2×ACT; 1×GOL; | ||||
Assess | ||||||
VIM-2 metallo-beta-lactamase in complex with ((S)-3-mercapto-2-methylpropanoyl)-D-tryptophan (Compo… | monomer | 3×ZN; 1×R38; 2×FMT; | ||||
Assess | ||||||
Structure of the VIM-2 Metallo-beta-Lactamase in Complex with a Bisthiazolidine Inhibitor | monomer | 2×ZN; 1×GOL; 2×3C7; | ||||
Assess | ||||||
VIM-2_1dh-Triazole inhibitors with promising inhibitor effects against antibiotic resistance metall… | monomer | 1×NL5; 2×ZN; 1×OH; 1×IOD; | ||||
Assess | ||||||
Crystal structure of VIM-2 complexed with compound 8 | monomer | 3×ZN; 1×P9T; 2×ACT; | ||||
Assess | ||||||
VIM-2_1di-Triazole inhibitors with promising inhibitor effects against antibiotic resistance metall… | monomer | 3×ZN; 1×OH; 2×CL; | ||||
Assess | ||||||
Structure of Zn(II)-bound metallo-beta-lactamse VIM-2 from Pseudomonas aeruginosa | monomer | 3×ZN; 2×ACT; | ||||
Assess | ||||||
VIM-2_10c. Metallo-beta-Lactamase Inhibitors by Bioisosteric Replacement: Preparation, Activity and… | monomer | 2×ZN; 1×8XW; | ||||
Assess | ||||||
Crystal Structure of the VIM-2 Acquired Metallo-beta-Lactamase in Complex with Taniborbactam (VNRX-… | monomer | 3×ZN; 2×ACT; 1×K9B; | ||||
Assess | ||||||
VIM-2_10b. Metallo-beta-Lactamase Inhibitors by Bioisosteric Replacement: Preparation, Activity and… | monomer | 2×ZN; 1×8XZ; 1×CL; 2×PO4; | ||||
Assess | ||||||
VIM-2, a Zn-beta-lactamase from Pseudomonas aeruginosa with Cys221 reduced | monomer | 3×ZN; 2×ACT; 1×CL; 1×OH; | ||||
Assess | ||||||
VIM-2 metallo-beta-lactamase in complex with (S)-1-allyl-2-(3-methoxyphenyl)-3-oxoisoindoline-4-car… | monomer | 2×ZN; 1×6TU; | ||||
Assess | ||||||
VIM-2 metallo-beta-lactamase in complex with (R)-2-(4-fluorophenyl)-2-((S)-3-mercapto-2-methylpropa… | monomer | 3×ZN; 1×8PL; 1×FMT; | ||||
Assess | ||||||
VIM-2, a Zn-beta-lactamase from Pseudomonas aeruginosa with an oxidized Cys (cysteinesulfonic) | monomer | 2×ZN; 2×ACT; | ||||
Assess | ||||||
Crystallographic Investigation of Inhibition Mode of the VIM-2 Metallo-beta-lactamase from Pseudomo… | monomer | 2×ZN; 2×SO4; 1×M5P; | ||||
Assess | ||||||
VIM-2 metallo-beta-lactamase in complex with 3-oxo-2-phenylisoindoline-4-carboxylic acid (compound … | monomer | 2×ZN; 1×MG; 1×6TJ; 2×GOL; | ||||
Assess | ||||||
VIM-2 metallo-beta-lactamase in complex with 3-oxo-2-(3-(trifluoromethyl)phenyl)isoindoline-4-carbo… | monomer | 2×ZN; 1×B06; 5×GOL; | ||||
Assess |
2 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
6kw1.1.A | homo-2-mer | 0.93 | 4×ZN; 2×MG; 2×9RX; | 100.00 | ||
Assess | ||||||
6bm9.2.A | homo-2-mer | 0.85 | 2×ZN; | 93.75 | ||
Assess |